Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.062 USD | -6.16% | -9.66% | -31.50% |
May. 10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
May. 07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.50% | 5.5M | |
+32.36% | 50.85B | |
+1.08% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+10.81% | 26.11B | |
-21.57% | 19.13B | |
+9.01% | 13.05B | |
+27.37% | 12.16B | |
+23.58% | 12.08B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Ladenburg Thalmann Starts Palisade Bio at Buy With $5 Price Target